Citius Oncology Inc (CTOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 33 | N/A | N/A | 370 | 120 |
| TOTAL | $94 | $N/A | $N/A | $462 | $245 |
| Non-Current Assets | |||||
| Investments And Advances | 48,585 | 0 | 0 | 69,389 | 68,573 |
| TOTAL | $48,585 | $N/A | $N/A | $69,389 | $68,573 |
| Total Assets | $48,679 | $N/A | $N/A | $69,850 | $68,818 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 537 | N/A | N/A | 350 | N/A |
| Accrued Expenses | 493 | N/A | N/A | 114 | 48 |
| Other current liabilities | 269 | N/A | N/A | N/A | N/A |
| TOTAL | $2,819 | $N/A | $N/A | $464 | $48 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 48,316 | 0 | 0 | 69,389 | 68,573 |
| TOTAL | $48,316 | $N/A | $N/A | $69,389 | $68,573 |
| Total Liabilities | $51,135 | $N/A | $N/A | $69,852 | $68,621 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,653 | 6,653 | 8,941 | 8,941 | 8,941 |
| Retained earnings | -2,456 | N/A | N/A | -2 | 197 |
| TOTAL | $-2,456 | $N/A | $N/A | $-2 | $198 |
| Total Liabilities And Equity | $48,679 | $0 | $0 | $69,850 | $68,818 |